Acasă › Rabdomiosarcom › Texas
Studii clinice pentru Rabdomiosarcom în Texas
9 studii pentru Rabdomiosarcom caută participanți în Texas.
Orașe în Texas
Text oficial al studiului (în engleză)
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- University of Texas - MD Anderson Cancer Center, Houston
În curs de recrutareFaza 1
24 Months – 18 Years · Toate sexele · Actualizat 25 sept. 2026 · NCT06441331Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Children's Medical Center, Dallas
În curs de recrutareFaza 1/2
Până la vârsta de 30 · Toate sexele · Actualizat 3 sept. 2026 · NCT06541262A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- și încă 2
În curs de recrutareFaza 3
Până la vârsta de 50 · Toate sexele · Actualizat 25 aug. 2026 · NCT07466316Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- Texas Children's Hospital, Houston
În curs de recrutareFaza 1
Vârste de la 1 la 21 · Toate sexele · Actualizat 6 aug. 2026 · NCT04715191PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Texas Children's Hospital, Houston
În curs de recrutareFaza 1/2
Vârste de la 1 la 30 · Toate sexele · Actualizat 22 iul. 2026 · NCT06721689Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
- Cook Children's Medical Center, Fort Worth
În curs de recrutareFaza 2
Până la vârsta de 22 · Toate sexele · Actualizat 15 iun. 2026 · NCT06023641VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- The University of Texas Southwestern Medical Center, Dallas
- Texas Children's Hospital, Houston
În curs de recrutareFaza 1/2
6 Months – 30 Years · Toate sexele · Actualizat 2 iun. 2026 · NCT04796012HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
- Texas Children's Hospital, Houston
În curs de recrutareFaza 1
Vârste de la 1 la 25 · Toate sexele · Actualizat 22 ian. 2026 · NCT04995003Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
- Houston Methodist Hospital, Houston
În curs de recrutareFaza 1
Până la vârsta de 21 · Toate sexele · Actualizat 3 nov. 2025 · NCT06198296Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.